Navigation Links
QIAGEN Announces Third Co-Development Program for Companion Diagnostics Paired With Lilly's Investigational Cancer Compounds
Date:11/18/2013

IAGEN is a leading partner globally in developing and validating companion diagnostics to transform patient care and extend lives by providing personalized genomic information to guide treatment decisions in cancer and other diseases. More than 15 projects with pharmaceutical and biotech companies are underway to create new companion diagnostics. In addition to the FDA-approved therascreen KRAS test, QIAGEN received FDA approval in July 2013 for the therascreen® EGFR RGQ PCR Kit as a companion diagnostic for a new targeted therapy in metastatic NSCLC patients whose tumors have certain gene mutations. Globally, QIAGEN offers the broadest portfolio of companion diagnostics, including the therascreen EGFR and KRAS kits in Japan, and more than 15 CE-marked assays for personalized healthcare applications in Europe.

About QIAGEN

QIAGEN N.V. is a Netherlands holding company publically traded on NASDAQ and Frankfurt Prime Standard. The Company is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular insights. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are then used to make these isolated biomolecules visible and ready for interpretation. QIAGEN markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). As of September 30, 2013, QIAGEN employed more than 4,100 people in over 35 locations worldwide. Further information can be found at http://www.qiagen.com.'/>"/>

SOURCE Qiagen N.V.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. QIAGEN Announces Partnership With Clovis Oncology to Co-develop Companion Diagnostic Targeting Drug-Resistant EGFR Mutations
2. QIAGEN Partners with Exosome Diagnostics to Create High-Performance Biofluid Sample Preparation Kits for Personalized Healthcare Research
3. QIAGEN Unveils Sample-to-Result Next-Generation Sequencing Workflow Designed for Clinical Research and Diagnostics
4. WaferGen Bio-systems and QIAGEN KK Sign Agreement for Co-Marketing in Japan
5. QIAGEN and Bayer HealthCare Partner to Develop Companion Diagnostics to Guide Treatment Decisions for Targeted Cancer Therapies
6. QIAGEN Acquires AmniSure International to Add Unique Assay to Emerging Point of Need Portfolio
7. QIAGEN Joins Grand Challenges in Global Health Initiative to Bring Advanced Point-of-Care Diagnostics to Worlds Poorest Countries
8. BioHealth Innovation, Inc. Appoints Qiagens Douglas Liu to Board of Directors
9. QIAGEN Gains Rights to Genomic Biomarkers for Lung, Brain and Other Cancers to Expand its Pipeline of Companion Diagnostics
10. QIAGEN and Max Planck Institute for Infection Biology Collaborate to Develop Assay for Active TB Risk in Individuals With Latent Infection
11. Sangamo BioSciences Announces Presentation Of Clinical Data From Alzheimers Disease Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... NEW YORK , Oct. 22, 2014 ... Diabetes Federation, approximately 400 million people worldwide are living ... 552 million people by 2030.  The global market for ... In 2012 approximately 330,000 people worldwide died from pancreatic ... of death due to cancer in the ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
(Date:10/20/2014)... Calif. , Oct. 20, 2014 ... that the Company has signed a Notice of ... Regenerative Medicine (CIRM), effective October 1, 2014.  The ... Development payments and the release of additional grant ... CIRM grant award for clinical development of Asterias, ...
(Date:10/20/2014)... , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Horovitz , Ph.D., from its board of directors effective on ... August 2003, and served as its chairman from June 2006 ... the Nominating and Corporate Governance and Audit Committees of the ... than a decade of dedicated service to GenVec, and its ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2
... NEW YORK, July 7, 2011 ... new market research report is available ... Tele-Health Monitoring: Market Shares, Strategies, and ... http://www.reportlinker.com/p0569001/Tele-Health-Monitoring-Market-Shares-Strategies-and-Forecasts-Worldwide-2011-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=e-Healthcare ...
... SAFC®, a member of the Sigma-Aldrich® Group (NASDAQ: ... first offering in a product line of Zinc Finger ... for use in the production of biopharmaceuticals, the CHOZN® ... the market faster and more cost-effectively by reducing timelines ...
... the space shuttle Atlantis will streak skyward from the Kennedy ... the STS-135 flight marks the end of the space shuttle,s ... of research into infectious diseases, thanks to space bound experiments ... with their colleagues at Arizona State University,s Biodesign Institute. ...
Cached Biology Technology:Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 2Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 3Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 4Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 5Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 6Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 7Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 8Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 9Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 10Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 11Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 12Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 13Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 14Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 15Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 16Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 17Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 18SAFC Launches CHOZN ZFN-modified CHO Cell Lines to Enhance Speed of Bioproduction 2SAFC Launches CHOZN ZFN-modified CHO Cell Lines to Enhance Speed of Bioproduction 3SAFC Launches CHOZN ZFN-modified CHO Cell Lines to Enhance Speed of Bioproduction 4Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage 2Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage 3Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage 4
(Date:10/14/2014)... shows SIRT6—a protein known to inhibit the growth ... skin cancers by turning on an enzyme that increases ... Previously considered protective, SIRT6 is part of a family ... stability and prevent some of the genetic flaws associated ... lead to cancer. This study, in the journal,s October ...
(Date:10/14/2014)... sequenced the house fly genome for the first time, ... an insect that thrives in pathogen-rich dung piles and ... the journal Genome Biology , will increase understanding ... flies quickly adapt to resist insecticides, which could lead ... domestica) carry and transmit more than 100 human and ...
(Date:10/14/2014)... kind of stem cell that can become either a liver ... to a study published today in the journal Stem ... contradicts current theory on how organs arise from cell layers ... and future treatment for, liver cancer., Thanks to stem cells, ... made up of more than 200 cell types. The original, ...
Breaking Biology News(10 mins):Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2House fly genome reveals expanded immune system 2Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 2Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 3
... infertility is a common medical problem, affecting millions of ... an inability to make productive sperm. Now, using yeast ... Pennsylvania School of Medicine are beginning to identify the ... Shelley Berger PhD, the Daniel S. Och ...
... The cave bear started to become extinct in Europe 24,000 ... international team of scientists has analysed mitochondrial DNA sequences from ... brown bear. The results show that the decline of the ... by human expansion than by climate change. "The decline ...
... Florida study indicates extinct carnivorous mammals shrank in size during a ... The study, scheduled to appear in the December print edition of ... describes a new species that evolved to half the size of ... hyena-like animal, Palaeonictis wingi , evolved from the size of ...
Cached Biology News:Swimming upstream: Molecular approaches to better understand male infertility 2Swimming upstream: Molecular approaches to better understand male infertility 3True causes for extinction of cave bear revealed 2UF study shows carnivore species shrank during global warming event 2
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
... to Protein A and, until recently, no readily ... IgM purification. Standard methods for IgM purification generally ... effective for removing all of the major impurities ... Pierce has developed an easy-to-use affinity matrix ...
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
Mouse monoclonal antibody to PARK2 - Parkinson disease (autosomal recessive, juvenile) 2, parkin...
Biology Products: